Bristol-Myers Squibb

Roche cancer drug taking bite out of Bristol's Opdivo
Yahoo/Reuters
Fri, 01/27/17 - 09:23 am
Roche
Bristol-Myers Squibb
Tecentriq
non-small cell lung cancer
Opdivo
Bristol-Myers Squibb Hits A New Low After Earnings
Seeking Alpha
Fri, 01/27/17 - 09:20 am
Bristol-Myers Squibb
earnings
Bristol-Myers Goes From Hunter to Target
Bloomberg
Thu, 01/26/17 - 06:54 pm
Bristol-Myers Squibb
M&A
Bristol-Myers Squibb stock sinks 2.7% after fourth-quarter earnings miss and downbeat outlook
Marketwatch
Thu, 01/26/17 - 10:23 am
Bristol-Myers Squibb
earnings
Earnings Preview: What To Expect From Bristol-Myers Squibb On Thursday
Forbes
Wed, 01/25/17 - 09:51 am
earnings
Bristol-Myers Squibb
Bristol-Myers a takeout target?: 4 plays
CNBC
Tue, 01/24/17 - 10:13 am
Bristol-Myers Squibb
M&A
JNJ
Sanofi
Pfizer
What’s Expected from Bristol-Myers Squibb’s 4Q16 Earnings?
Market Realist
Tue, 01/24/17 - 09:57 am
Bristol-Myers Squibb
earnings
Merck to pony up $625M plus Keytruda royalties to settle BMS, Ono patent fight
Fierce Pharma
Mon, 01/23/17 - 11:11 am
Merck
Keytruda
Bristol-Myers Squibb
Ono Pharmaceutical
Opdivo
patents
Bristol-Myers: An Activist Shows Up, Finally
Seeking Alpha
Mon, 01/23/17 - 10:21 am
Bristol-Myers Squibb
JANA Partners
Bristol-Myers shares drop after company says it will not seek fast-track drug approval
CNBC
Sat, 01/21/17 - 11:52 am
Bristol-Myers Squibb
fast track
lung cancer
Opdivo
Yervoy
Earnings preview: 7 biopharmas to watch
BioPharma Dive
Sat, 01/21/17 - 11:49 am
earnings
JNJ
Novartis
Vertex Pharmaceuticals
Biogen
Celgene
Bristol-Myers Squibb
AbbVie
Bristol-Myers Falls Further Behind Merck in Lung Cancer Race
Bloomberg
Thu, 01/19/17 - 11:32 pm
Bristol-Myers Squibb
Merck
lung cancer
Keytruda
Opdivo
U.S. top court to hear Bristol-Myers out-of-state injury appeal
Yahoo/Reuters
Thu, 01/19/17 - 11:29 pm
Plavix
Supreme Court
Bristol-Myers Squibb
Why Bristol-Myers Squibb May Be a Merger Target Soon
TheStreet.com
Tue, 01/17/17 - 11:03 am
Bristol-Myers Squibb
M&A
Opdivo
The Top 5 Drug Patents Expiring in 2017
Investopedia
Mon, 01/16/17 - 11:48 am
patents
Novartis
Eli Lilly
Merck
Bristol-Myers Squibb
Sandostatin LAR
Cubicin
Reyataz
Vytorin
Strattera
3 Takeover Candidates in the Drug Space
TheStreet.com
Mon, 01/9/17 - 09:45 am
M&A
Gilead Sciences
JNJ
Pfizer
Merck
Novartis
Eli Lilly
Bristol-Myers Squibb
Biogen
2 Big Reasons Merck & Co., Inc. Stock Surged 11% in 2016
Motley Fool
Sun, 01/8/17 - 03:18 pm
Merck
Keytruda
Opdivo
Bristol-Myers Squibb
3 Biggest Risks for Bristol-Myers Squibb in 2017
Motley Fool
Sun, 01/1/17 - 11:36 am
Bristol-Myers Squibb
Opdivo
Abilify
BMY’s Hepatitis C Franchise May See a Drop in Revenues in 2016
Market Realist
Thu, 12/22/16 - 10:26 am
Bristol-Myers Squibb
hepatitis C
Daklinza
Sunvepra
Opdivo Is a Key Growth Driver for Bristol-Myers Squibb in 2016
Market Realist
Thu, 12/22/16 - 10:23 am
Opdivo
Bristol-Myers Squibb

Pages